Mother of All Cannabis Stocks
Canopy Growth Corp. (NYSE: CGC) was born ready for 2019, and Trump's executive order on drug pricing should only drive its success further.
A Canada-based company, Canopy supplies several dispensaries – medicinal and recreational – across the United States, Virgin Islands, South America, Europe, Africa, and Australia.
Spectrum Therapeutics is the company's all-encompassing medical brand. Canopy has also partnered with Alcaliber, a world leader in the narcotics industry, and bought stake in medical cannabis industry leaders Auscann (Australia) and Storz & Bickel (Germany).
Currently, Spectrum Therapeutics is working around the world, in 11 different cities, to educate physicians on medical marijuana and spread the word on its literal colored "spectrum" of medicinal products.
Of course, the stock is getting a huge bump from the recreational side as well.
Alcoholic beverage companies Molson Coors Canada and the giant Constellation Brands Inc. (NYSE: STZ) have both committed to pursuing CBD-infused drinks with Canopy. In fact, Constellation now owns a 38% stake in the Canadian cannabis unicorn, as of last year.
News 
Market Data 
Discover 
